Search results for "Lost"

showing 10 items of 626 documents

Endoscopic treatment of recurrent sigmoid volvulus with colopexy assisted by T-fasteners and colostomy.

2016

Aged 80 and overMalemedicine.medical_specialtySigmoid Diseasesmedicine.diagnostic_testbusiness.industryGeneral surgerymedicine.medical_treatmentGastroenterologyColostomyT fastenersEndoscopy GastrointestinalEndoscopy03 medical and health sciences0302 clinical medicineRecurrence030220 oncology & carcinogenesisColostomyMedicineHumans030211 gastroenterology & hepatologySigmoid volvulusbusinessEndoscopic treatmentIntestinal VolvulusEndoscopy
researchProduct

Up-Regulation of leucocytes Genes Implicated in Telomere Dysfunction and Cellular Senescence Correlates with Depression and Anxiety Severity Scores

2012

BACKGROUND: Major depressive disorder (MDD) is frequently associated with chronic medical illness responsible of increased disability and mortality. Inflammation and oxidative stress are considered to be the major mediators of the allostatic load, and has been shown to correlate with telomere erosion in the leucocytes of MDD patients, leading to the model of accelerated aging. However, the significance of telomere length as an exclusive biomarker of aging has been questioned on both methodological and biological grounds. Furthermore, telomeres significantly shorten only in patients with long lasting MDD. Sensitive and dynamic functional biomarkers of aging would be clinically useful to eval…

AgingGene Expressionlcsh:MedicineAnxietySocial and Behavioral Sciences0302 clinical medicineBiomarkers of agingMolecular Cell BiologyLeukocytesPathologyPsychologylcsh:ScienceCellular SenescenceDepression (differential diagnoses)Psychiatry0303 health sciencesMultidisciplinaryDepressionChromosome BiologyGenomicsMiddle AgedTelomereAllostatic loadUp-RegulationTelomeresMental HealthMedicineMajor depressive disorderAnxietyBiomarker (medicine)Femalemedicine.symptomResearch ArticleAdultSenescenceClinical PathologyPsychological StressBiologybehavioral disciplines and activitiesMolecular Genetics03 medical and health sciencesDiagnostic Medicinemental disordersGeneticsmedicineHumansBiologyCyclin-Dependent Kinase Inhibitor p16030304 developmental biologyDepressive Disorder Majorlcsh:RComputational BiologyHuman GeneticsDNAmedicine.diseaseTelomereOxygenGene Expression RegulationImmunologyStathminlcsh:QBiomarkers030217 neurology & neurosurgeryDNA DamagePLoS ONE
researchProduct

Chapter 9 Nicotinic acetylcholine receptors on hippocampal neurons: cell compartment-specific expression and modulatory control of channel activity

1996

Publisher Summary The neuronal nicotinic acetylcholine receptors (nAChRs) are differentially expressed on the somato-dendritic surface of hippocampal neurons. This chapter demonstrates that various ions and drugs play a crucial role in modulating the activity of neuronal nAChRs. Considering the diversity of the neurotransmitter receptors and their binding sites and the diversity of substances, which can act simultaneously as a primary agonist of one receptor and an allosteric modulator of a different receptor, an enormous variety of combinatorial possibilities can be achieved in the brain giving rise to very complex neuronal networks. The characterization of the diversity of many receptors …

AgonistAllosteric modulatorNicotinic agonistnervous systemChemistrymedicine.drug_classNeurotransmitter receptormedicineAlpha-4 beta-2 nicotinic receptorReceptorLong-term depressionNeuroscienceAcetylcholine receptor
researchProduct

Oxytocin receptors: ligand binding, signalling and cholesterol dependence

2008

The G protein coupled oxytocin receptor (OTR) reveals some specific molecular and physiological characteristics. Ligand-receptor interaction has been analysed by photoaffinity labelling, site-directed mutagenesis, the construction of receptor chimeras and molecular modelling. Major results of these studies will be summarized. The N-terminus of the OTR is mainly involved in agonist binding. Notably, antagonists that are derived from the ground structure of oxytocin, bind the receptor at distinct sites partly non-overlapping with the agonist binding site. OTRs are able to couple to different G proteins, with a subsequent stimulation of phospholipase C-beta isoforms. In dependence on G protein…

AgonistBiochemistrymedicine.drug_classChemistryG proteinAllosteric regulationmedicineEnzyme-linked receptor5-HT5A receptorBinding siteReceptorOxytocin receptor
researchProduct

Introductory Lecture: Allosteric Modulation of Torpedo Nicotinic Acetylcholine Receptor Ion Channel Activity by Noncompetitive Agonists

1997

AbstractSimilar to other neuroreceptors of the vertebrate central nervous system, the nicotinic acetylcholine receptor (nAChR) is subject to modulatory control by allosterically acting ligands. Of particular interest in this regard are allosteric ligands that enhance the sensitivity of the receptor to its natural agonist acetylcholine (ACh), as such ligands could be useful as drugs in diseases associated with impaired nicotinic neurotransmission. Here we discuss the action of a novel class of nAChR ligands which act as allosterically potentiating ligands (APL) on the nicotinic responses induced by ACh and competitive agonists. In addition, APLs also act as noncompetitive agonists of very lo…

Agonistmedicine.drug_classChemistryAllosteric regulationCell BiologyPharmacologyBiochemistryNicotinic acetylcholine receptorNicotinic agonistGanglion type nicotinic receptorMuscarinic acetylcholine receptormedicineAlpha-4 beta-2 nicotinic receptorMolecular BiologyAcetylcholinemedicine.drugJournal of Receptors and Signal Transduction
researchProduct

Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease.

2000

Impairment of the central cholinergic system has a pivotal role in the cognitive decline observed in patients with Alzheimer’s disease (AD). One of the most prominent cholinergic deficits is the reduced number of nicotinic acetylcholine receptors (nAChR) in the brain. Since these receptors are important for memory and learning, enhancing nicotinic neurotransmission is a promising treatment strategy for AD. The two most common approaches to correcting these cholinergic deficits are to increase the synaptic availability of acetylcholine (ACh) by inhibiting acetylcholinesterase (AChE), or to mimic the effects of ACh (nicotinic agonists) by acting directly on nicotinic receptors. Clinical studi…

Agonistmedicine.drug_classGalantamineCognitive NeuroscienceAllosteric regulationCholinergic AgentsPharmacologyReceptors NicotinicAcetylcholinesteraseSynaptic TransmissionPsychiatry and Mental healthchemistry.chemical_compoundNicotinic agonistchemistryAlzheimer DiseaseGalantaminemedicineCholinergicHumansGeriatrics and GerontologyCognitive declineNeuroscienceAcetylcholinemedicine.drugDementia and geriatric cognitive disorders
researchProduct

Fibroblast Growth Factor Receptor 1– 5-Hydroxytryptamine 1A Heteroreceptor Complexes and Their Enhancement of Hippocampal Plasticity

2011

Background The hippocampus and its 5-hydroxytryptamine transmission plays an important role in depression related to its involvement in limbic circuit plasticity. Methods The analysis was made with bioluminescence resonance energy transfer, co-immunoprecipitation, in situ proximity ligation assay, binding assay, in cell western and the forced swim test. Results Using bioluminescence resonance energy transfer analysis, fibroblast growth factor receptor 1 (FGFR1)-5-hydroxytryptamine 1A (5-HT1A) receptor complexes have been demonstrated and their specificity and agonist modulation characterized. Their presence based on co-immunoprecipitation and proximity ligation assay has also been indicated…

Agonistmedicine.medical_specialtyReceptor complexmedicine.drug_classProximity ligation assayBiologyHippocampal formationTransfectionHeteroreceptorSettore BIO/09 - FisiologiaHippocampusRats Sprague-DawleyGrowth factor receptorInternal medicineFluorescence Resonance Energy TransfermedicineAnimalsHumansImmunoprecipitationReceptor Fibroblast Growth Factor Type 1Enzyme InhibitorsRNA Small InterferingCells CulturedBiological PsychiatryNeurons8-Hydroxy-2-(di-n-propylamino)tetralinNeuronal PlasticityDose-Response Relationship DrugFibroblast growth factor receptor 1Computational BiologyAllosteric modulation depression fibroblast growth factor receptor heteroreceptor neuronal plasticity serotonin receptorsRatsSerotonin Receptor AgonistsCell biologyEndocrinologyAnimals NewbornFibroblast growth factor receptorReceptor Serotonin 5-HT1AFibroblast Growth Factor 2PeptidesSignal TransductionBiological Psychiatry
researchProduct

Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.

2003

Galantamine (Reminyl), an approved treatment for Alzheimer's disease (AD), is a potent allosteric potentiating ligand (APL) of human alpha 3 beta 4, alpha 4 beta 2, and alpha 6 beta 4 nicotinic receptors (nAChRs), and of the chicken/mouse chimeric alpha 7/5-hydroxytryptamine3 receptor, as was shown by whole-cell patch-clamp studies of human embryonic kidney-293 cells stably expressing a single nAChR subtype. Galantamine potentiates agonist responses of the four nAChR subtypes studied in the same window of concentrations (i.e., 0.1-1 microM), which correlates with the cerebrospinal fluid concentration of the drug at the recommended daily dosage of 16 to 24 mg. At concentrations10 microM, gal…

Agonistmedicine.medical_specialtymedicine.drug_classRecombinant Fusion ProteinsAllosteric regulationPhenylcarbamatesRivastigminePharmacologyReceptors NicotinicMiceAllosteric RegulationPiperidinesInternal medicineMuscarinic acetylcholine receptormedicineGalantamineAnimalsHumansDonepezilReceptorTrichlorfonCells CulturedPharmacologyNeuronsChemistryGalantamineLigand (biochemistry)Receptors MuscarinicEndocrinologyNicotinic agonistIndansTacrineMolecular MedicineCholinergicCarbamatesCholinesterase Inhibitorsmedicine.drugThe Journal of pharmacology and experimental therapeutics
researchProduct

Data from: Effects of undergrowth removal and edge proximity on ground beetles and vascular plants in urban boreal forests

2019

Urban forests are regularly managed for human safety and aesthetic reasons, but they are crucial habitat for many species. Removals of undergrowth occur commonly in these forests, yet the ecological consequences of these operations are poorly understood. We sampled ground beetles (Coleoptera, Carabidae) and vascular plants along 20-m edge gradients in Finnish urban forests, in five stands treated 0.5−2.5 years earlier with undergrowth removal and in five untreated stands. We hypothesized that undergrowth removal and edge proximity would benefit opportunistic and open-habitat species, whereas shady-habitat species would be affected negatively. (1) Regarding carabids, diversity and evenness i…

Agrostis capillarisRichnessDryopteris filix-masMilium effusumNardus strictaRubus idaeusVaccinium myrtillusLeistus terminatusCarex canescensLinnaea borealisOxalis acetocellaLuzula luzuloidesParis quadrifoliaLonicera xylosteumPterostichus nigerGeranium sylvaticumCalamagrostis arundinaceusmedicine and health carePatrobus assimilisTaraxacum spFragaria vescaArtemisia vulgarisPterostichus diligensCalathus micropterusPterostichus oblongopunctatusCalathus melanocephalusPhleum pretenseDeschampsia flexuosaHypericum maculatumViola rivinianaPterostichus melanariusLife SciencesPterostichus nigritaActaea spicataUrtica dioicaMelampyrum pretenseEquisetum pretenseFestuca ovinaSorbus aucupariaRubus saxatilisAnisodactylus binotatusMedicineMelica nutansCarabidaeAmara lunicollisAnthriscus sylvestrisLuzula pilosaTrechus secalisPterostichus strenuousCarabus hortensisHarpalus tardusedge effectGalium albumVeronica officinalisBadister lacertosusAlchemilla spQuaternaryCychrus caraboidesDryopteris carthusianaMaianthemum bifoliumPatrobus atrorufusTrechus rivularisNotiophilus biguttatusGeum urbanumundergrowthVaccinium vitis-idaeaMelampyrum sylvaticumGymnocarpium dryopterisDeschampsia cespitosaLoricera pilicornisCarex acutaAmara communisRanunculus repensConvallaria majalisAthyrium filix-feminaRibes rubrumHoloceneCirsium arvensePoa chaixiiAegopodium podagrariaTrientalis europaeaLeistus ferrugineusEquisetum sylvaticumRanunculus acrisEpilobium montanumAcer platanoidesScrophularia nodosaHarpalus laevipesUrtica urensCarabus nemoralisHieracium sylvaticaCampanula rotundifoliaSynuchus vivalisEpilobium angustifoliumVeronica chamaedrys
researchProduct

Crystalline-state reaction with allosteric effect in spin-crossover, interpenetrated networks with magnetic and optical bistability.

2003

A net change: A fully reversible ligand substitution involving coordination/ uncoordination of gaseous water and pyrimidine induces the repetitive allosteric transformation of three interpenetrated nets into a single three-dimensional net. The transformation does not affect the crystallinity of the sample but alters significantly the spin-crossover transition; the compound shows magnetic and chromatic bistability (see picture).

Allosteric effectSpin crossoverChemical physicsChemistryNanotechnologyGeneral ChemistryState (functional analysis)sense organsGeneral MedicineCatalysisOptical bistabilityAngewandte Chemie (International ed. in English)
researchProduct